Persistent Asset Partners »

Vor Biopharma shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $141k 11k 13.08

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Vor Biopharma

Fcpm Iii Services B.v.
Frazier Life Sciences Management
RA Capital Management
VR Adviser
Paradigm Biocapital Advisors
Dr. Jeffrey R. Jay, M.D.
Susquehanna International
Caligan Partners
Vanguard Group
BlackRock
Sphera Funds Management
Laurion Capital Management
UBS Group
FMR
Findell Capital Management

View all funds holding Vor Biopharma